Sage Journals: Discover world-class research

Retricted access

Review article

First published 2021-11

A Review of Fam-Trastuzumab Deruxtecan-nxki in HER2-Positive Breast Cancer

Xoan Nguyen, Morgan Hooper, Jared Paul Borlagdan [...]

Annals of Pharmacotherapy

Open access

Review article

First published 2021

Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer

Daisuke Kotani, Kohei Shitara

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2025

Trastuzumab deruxtecan: An antibody-drug conjugates for non-small cell lung cancer

Nahida Siddiqui, Gojuvaka Sravanthi, Kanugonda Jashwanth Kumar Reddy [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2026

Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study

Taha Koray Sahin, Fatih Kemik, Harun Muglu [...]

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2025

Trastuzumab-deruxtecan shows interesting disease control in a multitreated patient with ERBB2 amplified parotid carcinoma,a case report

Camille Evrard, Jean-Michel Goujon, Claire Villalva [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2026

Serum HER2 extracellular domain as a predictive biomarker for trastuzumab deruxtecan treatment response in HER2-positive gastric cancer: a real-world study

Yukiya Narita, Ryosuke Kumanishi, Koshi Takahashi [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2025

Impact of early tumor shrinkage on survival outcomes in patients with HER2-positive advanced gastric cancer treated with trastuzumab deruxtecan in third- or later-line settings

Koshiro Fukuda, Hiroki Osumi, Keitaro Shimozaki [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2023

Cost-effectiveness of trastuzumab deruxtecan in previously treated human epidermal growth factor receptor 2-low metastatic breast cancer

Jiangping Yang, Jiaqi Han, Ni Zeng [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Efficacy and safety of trastuzumab deruxtecan in Chinese patients with HER2-positive and HER2-low advanced breast cancer: a multicenter,observational,real-world study

Die Sang, Yanfang Su, Yurong Zhang [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2026

Co-reported respiratory adverse events in trastuzumab deruxtecan–associated interstitial lung disease: A pharmacovigilance analysis of the FAERS database

Seda Jeral Evinç, Çağla Eyüpler Akmercan, Zeliha Birsin [...]

Journal of Oncology Pharmacy Practice

Search results